Aurora Cannabis R&D Spending Growth & History (ACB)

Aurora Cannabis's r&d spending was $4.0M for fiscal 2026.

View full Aurora Cannabis company overview

Aurora Cannabis annual r&d spending history

Aurora Cannabis annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20262026-03-31$4.0M$346,000+9.41%
20252025-03-31$3.7M$104,000+2.91%
20242024-03-31$3.6M−$1.3M−27.41%
20232023-03-31$4.9M
20222022-06-30$10.4M−$1.1M−9.24%
20212021-06-30$11.4M−$14.6M−56.02%
20202020-06-30$26.0M$11.2M+76.12%
20192019-06-30$14.8M$13.1M+780.17%
20182018-06-30$1.7M

Aurora Cannabis r&d spending trends

Between the periods ended 2018-06-30 and 2026-03-31, Aurora Cannabis's r&d spending increased from $1.7M to $4.0M, a change of $2.3M. The latest reported quarter, Q1 2027, shows $941,000.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Aurora Cannabis source filings ↗

Community posts

It’s quiet here.

No posts about ACB yet. Start the conversation.

Write the first post